对端粒维持机制的泛癌分析
Meline Hakobyan1, Hans Binder2, Arsen Arakelyan1
1Bioinformatics Group, Institute of Molecular Biology NAS RA, Yerevan, Armenia.
The Journal of biological chemistry
|May 19, 2024
概括
癌细胞使用两个主要途径来维持端粒 (染色体末端):端粒酶依赖 (TEL) 和替代端粒延长 (ALT). 这些途径的不同组合 (TMM表型) 影响患者的生存和治疗策略.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 端粒对基因组稳定性和细胞寿命至关重要.
- 失调的端粒维护机制 (TMM) 是癌症的标志,驱动不受控制的细胞增殖.
- 了解TMMs是开发有效癌症疗法的关键.
研究的目的:
- 使用癌症基因组图谱 (TCGA) 数据对TMM进行泛癌分析.
- 描述端粒酶依赖性 (TEL) 和替代端粒延长 (ALT) 途径活动.
- 研究不同TMM表型的临床影响和生物关联.
主要方法:
- 在33种癌症类型中分析了TCGA的RNA测序数据.
- 根据ALT和TEL活性水平将瘤分为五种TMM表型.
- 进行基因本体学分析以确定丰富的生物过程.
主要成果:
- 确定了五种不同的TMM表型 (例如,ALT高 TEL低,ALT低 TEL高).
- 将特定的TMM个人资料与不同的患者生存模式联系起来,表明预后价值.
- 揭示了TMM表型与细胞周期调节,DNA复制和染色体动态之间的关联.
结论:
- TMM 分析具有作为癌症预后指标的潜力.
- 了解TMM异质性可以帮助开发个性化癌症治疗策略.
- 端粒维护与控制癌症增殖和基因组稳定性的基本细胞过程密切相关.
相关概念视频
Telomeres and Telomerase
23.3K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.3K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Replication in Eukaryotes
13.7K
In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
13.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


